"Myomo, Inc. is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis."

During the past decade, myomo Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "myomo Inc." #1 collaborator was "Geauga Rehabilitation Engineering, Inc." with 2 trials as a collaborator and "Orthocare Innovations, LLC" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "myomo Inc." are "Brachial Plexus Injury" (2 trials), "Neurological Disease" (2 trials), "Spinal Cord Injuries" (2 trials), "Stroke" (2 trials) and "CVA (Cerebrovascular Accident)" (1 trials). Many other conditions were trialed in "myomo Inc." in a lesser frequency.

Most popular intervention types in "myomo Inc." are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Myoelectric Elbow-Wrist-Hand Orthosis" (2 trials) and "myomo e100 neurorobotic elbow brace" (1 trials). Other intervention names were less common.

The vast majority of trials in "myomo Inc." are 3 trials for "All" genders.

Currently, there are NaN active trials in "myomo Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in myomo Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in myomo Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".